Clinical Scorecard: Ethnic Variations in Extrahepatic Manifestations in Chronic HCV Patients: A Population-Based Analysis in British Columbia
At a Glance
Category
Detail
Condition
Chronic hepatitis C virus (HCV) infection with extrahepatic manifestations (EHMs)
Key Mechanisms
HCV infection associated with increased risk of EHMs including chronic kidney disease, type 2 diabetes, cardiovascular events, stroke, and neurocognitive disorders; ethnic disparities influence incidence and risk
Target Population
Individuals with chronic HCV infection in British Columbia, Canada, focusing on East Asian, South Asian, and other ethnic groups
Care Setting
Population-based healthcare setting with universal access to medical services and HCV treatment
Key Highlights
South Asian and East Asian individuals with chronic HCV have higher incidence rates of CKD, ESRD, type 2 diabetes, stroke, and major adverse cardiac events compared to other ethnicities, especially if untreated.
HCV treatment reduces ethnic disparities in EHMs, with most differences disappearing post-treatment except for persistent higher diabetes risk among South Asians.
Public health efforts are needed to improve linkage to HCV treatment among untreated ethnic minority populations to reduce extrahepatic disease burden.
Guideline-Based Recommendations
Diagnosis
Screen individuals with chronic HCV infection for extrahepatic manifestations including CKD, T2DM, cardiovascular disease, stroke, and neurocognitive disorders.
Consider ethnicity as a factor in risk stratification for EHMs among HCV-infected patients.
Management
Prioritize timely HCV treatment to reduce the risk and ethnic disparities of EHMs.
Implement targeted public health programs to increase treatment uptake among South Asian and East Asian populations.
Monitor and manage persistent risks such as type 2 diabetes even after HCV treatment, especially in South Asian patients.
Monitoring & Follow-up
Regularly monitor kidney function, glycemic control, cardiovascular status, and neurocognitive function in chronic HCV patients, with heightened vigilance in Asian ethnic groups.
Follow up post-HCV treatment to assess resolution or persistence of EHMs.
Risks
Untreated chronic HCV infection in South Asian and East Asian populations carries increased risk of CKD, ESRD, T2DM, stroke, and major adverse cardiac events.
Delays in diagnosis and treatment contribute to advanced liver and extrahepatic disease outcomes in ethnic minorities.
Patient & Prescribing Data
Chronic HCV-infected individuals from diverse ethnic backgrounds in British Columbia, including untreated, treated, and spontaneously cleared groups.
HCV treatment (interferon-based or direct-acting antivirals) substantially reduces ethnic disparities in EHMs, highlighting the importance of treatment access and adherence.
Clinical Best Practices
Incorporate ethnicity-specific risk assessment for EHMs in chronic HCV management protocols.
Enhance screening and early diagnosis efforts in high-risk ethnic groups to prevent progression of EHMs.
Promote equitable access to HCV treatment to mitigate ethnic disparities in extrahepatic disease burden.
Maintain long-term monitoring for diabetes and cardiovascular complications even after successful HCV treatment.
by Dahn Jeong, Stanley Wong, Héctor A Velásquez García, Prince A Adu, Jean D Makuza, Sofia R Bartlett, Alnoor Ramji, Eric M Yoshida, Richard L Morrow, Amee R Manges, Mohammad E Karim, Amanda Yu, Georgine Cua, Mel Krajden, Naveed Z Janjua
So get this: sodium may track with memory decline (in men), steroids might not be “immunosuppressive” in the ICU, and second pregnancies reshape the brain differently than first. Same theme: biology is less binary than we teach it.
